Atacand HCT — Medica
post-myocardial infarction left ventricular failure or dysfunction (for valsartan oral solution when unable to swallow tablets)
Preferred products
- generic candesartan tablets
- generic candesartan/HCTZ tablets
- generic eprosartan tablets
- generic irbesartan tablets
- generic irbesartan/HCTZ tablets
- generic losartan tablets
- generic losartan/HCTZ tablets
- generic olmesartan tablets
- generic olmesartan/amlodipine tablets
- generic olmesartan/HCTZ tablets
- generic olmesartan/amlodipine/HCTZ tablets
- generic telmisartan tablets
- generic telmisartan/amlodipine tablets
- generic telmisartan/HCTZ tablets
- generic valsartan tablets
- generic valsartan/amlodipine tablets
- generic valsartan/HCTZ tablets
- generic valsartan/amlodipine/hydrochlorothiazide tablets
Initial criteria
- Patient has tried one Step 1 Product within the 130-day look-back period OR
- Patient cannot swallow or has difficulty swallowing tablets (only for valsartan oral solution or Arbli)
Reauthorization criteria
- Same criteria as initial approval
Approval duration
1 year